• 1. Department of Cardiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, P. R. China;
  • 2. Department of Cardiology, The First People’s Hospital of Foshan, Foshan, 528000, Guangdong, P. R. China;
LI Jie, Email: leomoku1981@163.com
Export PDF Favorites Scan Get Citation

Patients with bicuspid aortic valve (BAV) are characterized by asymmetric anatomy, severe calcification and combined aortic dilatation. Compared with tricuspid aortic valve stenosis patients, patients with BAV stenosis confront with greater surgical risks in transcatheter aortic valve replacement (TAVR), including paravalvular leak, aortic valve rupture, coronary artery obstruction, atrioventricular block and so on. However, with the advent of new generation of prosthetic valves and optimization of surgical strategies, several studies have shown that TAVR is safe and effective in the treatment of BAV stenosis. Therefore, we aim to provide an overview of the use of TAVR in patients with BAV stenosis.

Citation: LI Weijie, LUO Jianfang, SUN Yinghao, CHEN Jiaohua, LUO Songyuan, LI Jie. Research progress of application of transcatheter aortic valve replacement in the bicuspid aortic valve stenosis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(8): 1199-1203. doi: 10.7507/1007-4848.202211085 Copy

  • Previous Article

    Progress of transcatheter aortic valve replacement in patients with atrioventricular regurgitation
  • Next Article

    Research progress of intravital microscopy of the pulmonary immune environment